Singapore, July 21 -- CorestemChemon, a leading GLP-certified preclinical CRO based inSouth Korea, has entered into a strategic partnership with ATG Lifetech, a biotechnology startup specialising in transcriptome analytics and organoid-based modeling.

This collaboration aims to deliver next-generation, precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures across the US,Europe, andAsia.

Through this partnership, the two companies will co-develop:

Organoid-based assays are increasingly recognized for their translational advantage, offering up to5x greater predictive accuracyin toxicity and efficacy screening compared to conventional 2D cell cultures, according to industry benchmarks. When integrated wit...